Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Myelosafe PG Tablet

Prescription Icon
Prescription Required

Marketer

S R Pharmaceuticals

Salt Composition

Lenalidomide (NA)

Overview Myelosafe PG Tablet

Immunomodulatory Myelosafe PG tablets influence your body's immune response. Prescribed for multiple myeloma and myelodysplastic syndromes, they can be ingested with or without food, ideally at a consistent time daily for optimal efficacy. Dosage and frequency are determined by your physician, dependent on your condition and subject to adjustment. Strictly adhere to your doctor's instructions; improper usage or overdose may lead to severe adverse effects. Therapeutic benefits might not be immediately apparent, requiring weeks or months; discontinue only upon your doctor's recommendation. Common side effects include headache, fatigue, nausea, skin rash, and dizziness, among others. This medication can lower blood cell counts (red and white), increasing infection and bleeding risks. Avoid activities promoting bleeding and contact with contagious individuals. Regular blood tests are crucial to monitor blood cell levels. Inform your healthcare provider of all other medications you are taking, as interactions are possible. Use during pregnancy or breastfeeding is discouraged, and effective contraception is essential for both partners throughout treatment. Maintain adequate hydration by drinking ample fluids.

Uses of Myelosafe PG Tablet

Managing multiple myeloma and myelodysplastic syndromes

Major Benefits of Myelosafe PG Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Myelosafe PG Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Myelosafe PG Tablet:

  • Headache
  • Nausea
  • Rash
  • Breathlessness
  • Dizziness
  • Fatigue
  • Decreased white blood cell count (neutrophils)
  • Joint pain
  • Itching
  • Diarrhea
  • Low blood platelets
  • Peripheral edema
  • Cough
  • Back pain
  • Upper respiratory tract infection
  • Decreased appetite
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Myelosafe PG Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Myelosafe PG Tablet can be administered with or without food, although consistent timing is recommended.

How Myelosafe PG Tablet works:

Myelosafe PG Tablets combat cancer by bolstering the body's natural defenses to indirectly target malignant cells. The medication inhibits tumor angiogenesis, preventing the formation of new blood vessels that nourish cancerous growths. Furthermore, it suppresses the production of signaling molecules, including cytokines and growth factors, crucial for cancer cell proliferation, thus hindering tumor development.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Myelosafe PG Tablet poses an unknown safety risk. Seek medical advice before combining them.

PregnancyPregnancyUNSAFE

Using Myelosafe PG Tablet while pregnant is strongly discouraged due to substantial risks. Pregnant women should consult their physician; research in animals and pregnant humans indicates considerable harm to the fetus.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Myelosafe PG Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Myelosafe PG Tablet may induce side effects such as dizziness, fatigue, drowsiness, vertigo, or blurred vision, potentially impairing driving ability.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Myelosafe PG Tablets, as dosage modification may be necessary. A physician's consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Myelosafe PG Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Myelosafe PG Tablet :

Should you forget a Myelosafe PG Tablet dose, administer it at your earliest convenience. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Myelosafe PG Tablet

LabelValue
Chemical Type Phthalimide and Piperidone Derivatives
Developing Habits No.
Treatment Category Cancer Medications
Action Class Thalidomide and Immunomodulatory Drugs (IMiDs)

FAQs on Myelosafe PG Tablet

Take Myelosafe PG Tablet with or without food, as directed by your doctor. Swallow the tablet whole with water; do not crush, cut, or chew it. Take it at approximately the same time each day.
Myelosafe PG Tablets are administered to dialysis patients post-dialysis. Dosage adjustments may be made by the physician as clinically indicated.
Myelosafe PG Tablet may produce side effects such as diarrhea, constipation, stomach pain, appetite loss, weight loss, weakness, dizziness, altered taste, and mouth or throat pain or burning. Other possible side effects include reduced sense of touch, tingling or burning in extremities, sleep disturbances, depression, and musculoskeletal pain. You might also experience sweating, dry skin, abnormal hair growth (women), tremors, changes in libido or sexual function, and urinary frequency, urgency, or pain. Report any persistent or severe symptoms to your doctor.
Patients with multiple myeloma undergoing melphalan chemotherapy and stem cell transplantation, particularly those using Myelosafe PG Tablet, face an increased risk of secondary cancers. These may include acute myelogenous leukemia (AML), other blood cancers, and Hodgkin lymphoma. Discuss this potential risk with your physician if you are taking Myelosafe PG Tablet.
Before and throughout your Myelosafe PG Tablet treatment, regular blood tests are necessary to monitor your blood cell counts. Your doctor will request a blood test before treatment begins, weekly for the first eight weeks, and at least monthly thereafter. This is crucial because Myelosafe PG Tablet can reduce white blood cells (which fight infection) and platelets (which aid blood clotting).
Women of childbearing age must use two reliable birth control methods for four weeks before, during (including treatment breaks), and four weeks after Myelosafe PG Tablet treatment. Men taking Myelosafe PG Tablet must consistently use condoms during sexual contact, regardless of vasectomy status, for the duration of treatment, any breaks, and for four weeks post-treatment.
Myelosafe PG Tablet
91
MRP 105
13% off